Superfast Magnetic Resonance Imaging-based Diagnostic Pathway for Prostate Cancer

We describe a <36-h superfast diagnostic pathway for men at risk of prostate cancer (PCa) that was initiated in our centre in March 2022. Patients are scheduled to undergo a repeat prostate-specific antigen blood test, magnetic resonance imaging, a urology consultation, and, if indicated, prostat...

Descripción completa

Detalles Bibliográficos
Autores principales: Paulino Pereira, Leonor Jane, Heetman, Joris G., van den Bergh, Roderick C.N., van Melick, Harm H.E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Open Horizon
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615134/
https://www.ncbi.nlm.nih.gov/pubmed/36310760
http://dx.doi.org/10.1016/j.euros.2022.09.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615134/
https://www.ncbi.nlm.nih.gov/pubmed/36310760
http://dx.doi.org/10.1016/j.euros.2022.09.017

Ejemplares similares